Possible pharmaceutical applications can be developed from naturally occurring phenanthroindolizidine and phenanthroquinolizidine alkaloids.

Naturally occurring phenanthroindolizidine and phenanthroquinolizidine alkaloids (PIAs and PQAs) are two small groups of herbal metabolites sharing a similar pentacyclic structure with a highly oxygenated phenanthrene moiety fused with a saturated or an unsaturated N-heterocycle (indolizidine/quinolizidine moieties). Natural PIAs and PQAs only could be obtained from finite plant families (such as Asclepiadaceae, Lauraceae and Urticaceae families, etc.). Up to date, more than one hundred natural PIAs, while only nine natural PQAs had been described. PIA and PQA analogues have been applied to the development of potent anticancer agents all along because of their excellent cytotoxic activity. However, in the last two decades, other great biological properties, such as anti-inflammatory and antiviral activities were revealed successively by different pharmacological assays. Especially because of their potent antiviral activity against coronavirus (TGEV, SARS CoV and MHV) and tobacco mosaic virus, PIA and PQA analogues have attracted much pharmaceutical attention again, some of them have been used to present interesting targets for total or semi synthesis, and structure-activity relationship (SAR) study for the development of antiviral agents. In this review, natural PIA and PQA analogues obtained in the last two decades with their herbal origins, key spectroscopic characteristics for structural identification, biological activity with possible SARs and application prospects were systematically summarized. We hope this paper can stimulate further investigations on PIA and PQA analogues as an important source for potential drug discovery. © Springer Nature B.V. 2020.

Introduction

Phenanthroindolizidine and phenanthroquinolizidine alkaloids (PIAs and PQAs) are two small groups of natural bioactive products with similar molecular skeletons, belonging to indolizidine and quinolizidine alkaloid family, respectively. They commonly possess a pentacyclic structure with a phenanthrene moiety fused by a saturated or an unsaturated indolizidine/quinolizidine group (Fig. 1). Natural PIAs and PQAs only could be obtained from few plant families, such as Asclepiadaceae, Lauraceae and Urticaceae families, etc. (Tables 1 and 2). The first isolation of PIAs was (R)-tylophorine (1) from Tylophora indica (Asclepiadaceae family), an herbal medicine used for the treatment of asthma as well as bronchitis, rheumatism and dysentery in India (Rathnagiriswaran and Venkatachalam 1935). (R)-cryptopleurine (81) was the first isolated PQA analogue from Cryptocarya pleurosperma (Lauraceae family) reported in 1948 (Lande 1948). Up to date, more than one hundred natural PIAs, while only nine natural PQA analogues had been described from herbal origins (Table 3).

Fig. 1

Structure skeletons of PIAs (I) and PQAs (II)

Table 1

Herbal origins of natural PIAs

No.	Latin name of natural source	Plant family	Name abbreviation
1	Tylophora indica (Burm. f.) Merr.	Asclepiadaceae	T. indica
2	Tylophora tanakae Maxim. ex Franch. & Sav.		T. tanakae
3	Tylophora atrofolliculata F.P. Metcalf		T. atrofolliculata
4	Tylophora ovata (Lindl.) Hook. ex Steud.		T. ovata
5	Vincetoxicum pumilum Decne.		V. pumilum
6	Cynanchum vincetoxicum (L.) Pers.		C. vincetoxicum
7	Cynanchum komarovii Al. Iljinski		C. komarovii
8	Antitoxicum funebre Boiss and Kotschy		A. funebre
9	Ficus septica Burm.f.	Moraceae	F. septica
10	Ficus fistulosa var. tengerensis (Miq.) Kuntze		F. fistulosa var. tengerensis
11	Ficus fistulosa Reinw ex. Blume		F. fistulosa
12	Ficus hispida L.f.		F. hispida
13	Cryptocarya chinensis (Hance) Hemsl.	Lauraceae	C. chinensis
14	Cryptocarya densiflora Blume		C. densiflora
15	Cryptocarya laevigata Blume		C. laevigata

Herbal origins of natural PIAs presented in this Table were described in the literature of isolation only reported after the year 2000

The plant Latin names were presented according to the classification at http://www.theplantlist.org

Table 2

Herbal origins of natural PQAs

No.	Latin name of natural source	Plant family	Name abbreviation
1	Cryptocarya pleurosperma White & Francis	Lauraceae	C. pleurosperma
2	Cryptocarya laevigata Blume		C. laevigata
3	Boehmeria cylindrica (L.) Sw.	Urticaceae	B. cylindrica
4	Boehmeria siamensis Craib		B. siamensis
5	Boehmeria pannosa Nakai & Satake ex Oka		B. pannosa
6	Boehmeria caudata Sw.		B. caudata
7	Boehmeria platyphylla Don.		B. platyphyll
8	Pilea aff. martinii (Lévl.) Hand.-Mazz.		P. aff. martinii
9	Citsus rheifofia Planch.	Vitaceae	C. rheifofia

Herbal origins of natural PQAs presented in this Table were all described in the literature of isolation up to date

The plant Latin names were presented according to the classification at http://www.theplantlist.org

Table 3

The distribution of PIAs and PQAs in natural origins

Compounds	Name	Origins	References
PIAs*
1	R-tylophorine	F. septica T. tanakae	Damu et al. (2009) Stærk et al. (2002) Nakano et al. (2015)
2	R-antofine	V. pumilum C. komarovii F. septica C. vincetoxicum F. fistulosa C. densiflora C. chinensis	Stærk et al. (2005) An et al. (2001) Damu et al. (2009) Stærk et al. (2002) Subramaniam et al. (2009) Othmanan et al. (2017) Wu et al. (2012)
3	Ficuseptine B	F. septica	Damu et al. (2005)
4	Ficuseptine C	F. septica	Damu et al. (2005)
5	Ficuseptine D	F. septica	Damu et al. (2005)
6	Ficuseptine E	F. septica	Damu et al. (2009)
7	Ficuseptine F	F. septica	Damu et al. (2009)
8	Ficuseptine G	F. septica	Damu et al. (2009)
9	Ficuseptine H	F. septica	Damu et al. (2009)
10	Ficuseptine H	F. septica	Damu et al. (2009)
11	R-isotylocrebrine	F. septica	Damu et al. (2009)
12	R-tylocrebrine	F. septica	Damu et al. (2009)
13	Tylophoridicine A	T. indica	Dhiman et al. (2013)
14	13aR-6-O-desmethylantofine	C. vincetoxicum	Stærk et al. (2002)
15	13aR-7-O-desmethyltylophorine	T. tanakae	Stærk et al. (2002) Nakano et al. (2015)
16	13aR-2-hydroxyltylophorinine	T. atrofolliculata	Chen et al. (2016)
17	Tylophovatine C	T. ovata	Lee et al. (2011)
18	O-methyl-tylophorinidine	T. ovata	Lee et al. (2011)
19	(13aR,14S)-3,6,7-trimethoxy-14-hydrophenanthroindolizidine	T. atrofolliculata	Xiang et al. (2002)
20	(13aR,14S)-3,7-dimethoxy-6,14-dihydrophenanthroindolizidine	T. atrofolliculata	Xiang et al. (2002)
21	S-tylophorine	F. septica T. ovata T. atrofolliculata	Wu et al. (2002) Lee et al. (2011) Chen et al. (2016)
22	13aS-2,6-didemethyltylophorine	T. atrofolliculata	Chen et al. (2016)
23	13aS-6-desmethyltylophorine	T. ovata	Lee et al. (2011)
24	(+)-tylocrebrine	F. septica	Wu et al. (2002)
25	Deoxytylophorinine (20)	T. atrofolliculata	Chen et al. (2016)
26	13aS-3-demethylisotylocrebrine	T. ovata	Lee et al. (2011)
27	13aS-isotylocrebrine	F. septica T. tanakae	Wu et al. (2002) Stærk et al. (2002) Nakano et al. (2015)
28	2-hydroxyltylophorinidine	T. atrofolliculata	Chen et al. (2016)
29	3-O-demethyltylophorinidine	T. atrofolliculata	Chen et al. (2016)
30	Tylophorinidine	T. indica T. atrofolliculata	Dhiman et al. (2013) Xiang et al. (2002) Chen et al. (2016)
31	Tylophoridicine E (13aS,14S)-3,14-dihydroxy-6,7dimethoxylphenanthroindolizidine	T. atrofolliculata T. ovata	Huang et al. (2004) Chen et al. (2016) Lee et al. (2011)
32	O-methyltylophorinidine (13aS,14S)-3,6,7-trimethoxy-14-hydroxyphenanthroindolizidine	T. atrofolliculata	Chen et al. (2016)
33	(13aS,14S)-3,14-dihydroxy-4,6,7-trimethoxyphenanthroindolizidine	T. ovata T. atrofolliculata	Lee et al. (2011) Xiang et al. (2002)
34	11-ketotylophorinidine	T. atrofolliculata	Chen et al. (2016)
35	11-keto-O-methyltylophorinidine	T. atrofolliculata	Chen et al. (2016)
36	6-O-β-D-glucopyranosyl-tylophorinidine	T. atrofolliculata	Chen et al. (2019a)
37	Tylophorinine	T. indica T. atrofolliculata	Dhiman et al. (2013) Chen et al. (2016)
38	(13aS,14R)-6,7-dimethoxy-3,14-dihydrophenanthroindolizidine	T. atrofolliculata	Huang et al. (2004)
39	Hispiloscine	F. hispida	Yap et al. (2015)
40	Tengechlorenine	F. fistulosa var. tengerensis	Al-Khdhairawi et al. (2017)
41	10S,13aR-antofine N-oxide	V. pumilum T. indica	Stærk et al. (2005) Dhiman et al. (2013)
42	10S,13aR-tylocrebrine N-oxide	F. septica	Damu et al. (2005) Damu et al. (2009)
43	10S,13aR-isotylocrebrine N-oxide.	F. septica	Damu et al. (2005) Damu et al. (2009)
44	Ficuseptine K	F. septica	Damu et al. (2009)
45	Ficuseptine L	F. septica	Damu et al. (2009)
46	Tylophorine N-oxide	T. tanakae	Nakano et al. (2015)
47	(-)-14β-hydroxy-10β,13aα-antofine N-oxide	V. pumilum	Stærk et al. (2005)
48	10S-2-hydroxyl-6-demethyltylophorinine N-oxide	T. atrofolliculata	Chen et al. (2016)
49	Tylophorinine N-oxide	T. atrofolliculata	Chen et al. (2016)
50	14β-hydroxytylophorine N-oxide	T. tanakae	Nakano et al. (2015)
51	Ficuseptine N	F. septica	Damu et al. (2009)
52	3-demethyl-14α-hydroxyisotylocrebrine N-oxide	T. tanakae	Nakano et al. (2015)
53	10R,13aS-tylophorine N-oxide	F. septica T. atrofolliculata	Wu et al. (2002) Chen et al. (2016)
54	10R-deoxytylophorinine N-oxide	T. atrofolliculata	Chen et al. (2016)
55	10R,14R-3-O-demethyltylophorinidine N-oxide	T. atrofolliculata	Chen et al. (2016)
56	10R-2-hydroxyltylophorinine N-oxide	T. atrofolliculata	Chen et al. (2016)
57	10R-2-methyl-O-methyltylophorinidine N-oxide	T. atrofolliculata	Chen et al. (2016)
58	Ficuseptine M	F. septica	Damu et al. (2009)
59	Ficuseptine A	F. septica	Wu et al. (2002) Damu et al. (2009)
60	14α-hydroxyisotylocrebrine N-oxide	F. septica	Wu et al. (2002)
61	10S,13aS-isotylocrebrine N-oxide	F. septica T. tanakae	Damu et al. (2005) Nakano et al. (2015)
62	Tylophoridicine C (13aS,14S)-6,14-dihydroxy-3,7-dimethoxyphenanthroindolizidine N-oxide	T. atrofolliculata	Huang et al. (2004) Chen et al. (2016)
63	3-demethyl-14α-hydroxyisotylocrebrine N-oxide	T. tanakae	Nakano et al. (2015)
64	Tylophoridicine F (13aS,14R)-3,6,7-trimethoxy-14-hydrophenanthroindolizidine N-oxide	T. atrofolliculata	Huang et al. (2004)
65	10R,13aR-tylophorine N-oxide	F. septica	Damu et al. (2005)
66	10R,13aR-tylocrebrine N-oxide	F. septica	Damu et al. (2005)
67	Tylophoridicine D	T. atrofolliculata T. indica F. septica	Chen et al. (2016) Dhiman et al. (2013) Kubo et al. (2016)
68	Dehydrotylophorine	F. septica	Damu et al. (2009) Kubo et al. (2016) Wu et al. (2002)
69	Dehydroantofine	F. septica C. chinensis	Kubo et al. (2016) Wu et al. (2012)
70	Ficuseptine I	F. septica	Damu et al. (2009)
71	13aR-secoantofine	C. vincetoxicum F. fistulosa	Stærk et al. (2002) Subramaniam et al. (2009)
72	13aR-6-O-desmethylsecoantofine	C. vincetoxicum C. densiflora	Stærk et al. (2002) Othman et al. (2017)
73	Fistulopsine A	F. fistulosa	Yap et al. (2016)
74	Tylophovatine A	T. ovata	Lee et al. (2011)
75	(S)-(+)-hispidine	T. ovata	Lee et al. (2011)
76	Tylophovatine B	T. ovata	Lee et al. (2011)
77	(S)-(+)-septicine	T. ovata	Lee et al. (2011)
78	Fistulopsine B	F. fistulosa	Yap et al. (2016)
79	(−)-desmethylsecoantofine N-oxide	C. densiflora	Othmanan et al. (2017)
80	4a,b-seco-dehydroantofine	F. septica	Kubo et al. (2016)
PQAs**
81	(R)-cryptopleurine	C. pleurosperma C. laevigata B. cylindrica B. caudata B. pannosa P. aff. martinii	Lande (1948) Hoffmann et al. (1978) Krmpotic et al. (1972) Hoffmann et al. (1978) Cai et al. (2006) Thuy et al. (2019)
82	(R)-boehmeriasin A	B. siamensis	Luo et al. (2003)
83	Cryptopleuridine	C. pleurosperma	Johns et al. (1970)
84	(14aR,15R)-hydroxycryptopleurine	B. pannosa	Cai et al. (2006)
85	Boehmeriasin B	B. siamensis	Luo et al. (2003)
86	Pileamartine C	P. aff. martinii	Thuy et al. (2019)
87	Pileamartine D	P. aff. martinii	Thuy et al. (2019)
88	Kayawongine	C. rheifolia	Saifah et al. (1983)
89	Julandine	P. aff. martinii	Thuy et al. (2019)

*Natural PIAs presented in this Table were all isolated after the year 2000, those PIA analogues obtained before had been summarized in a few reviews (Govindachari and Viswanathan 1978; Gellert 1982; Li et al. 2001)

**All nine isolated PQA analogues up to date were presented in this Table

Although (R)-tylocrebrine (12) was advanced to clinical trials but failed due to its central nervous system (CNS) toxicity, naturally occurring PIAs and PQAs have been applied to the development of potent anticancer agents all along because of their excellent biological activities. Meanwhile, significant effort also has been expended in the total or semi synthesis and structure–activity-relationship (SAR) studies on the anti-cancer activity along with the specific biomolecular targets of these compounds. A series of reviews mainly highlighted important contributions to the PIA and PQA derivatives with synthetic methods and anticancer activities had been summarized successively (Gellert 1982; Li et al. 2001; Chemler 2009; de Fatima et al. 2015), while only Gellert and Li with his co-workers briefly involved those naturally occurring PIAs and PQAs isolated before the year 2000.

In the last two decades, many other new natural PIA and PQA analogues were isolated continuously, and they also have been attracted much attention again because of other biological activities, such as significant anti-inflammatory effect and antiviral activity against coronavirus even in nanomolar level. Furthermore, some natural PIA and PQA analogues, such as (R)-antofine (2) and (R)-cryptopleurine (81), displayed great inhibitory effects against plant-pathogenic fungi of Penicillium species, against plant insect of Spodoptera litura and Lipaphis erysimi, and especially against tobacco mosaic virus (TMV). PIA and PQA analogues have represented interesting targets for total or semi synthesis, and SARs study on natural product-based agrochemicals. However, no systematic review of various aspects related to these two kinds of analogues has yet been reported at present. In order to offer a comprehensive understanding of PIAs and PQAs, this paper summarized the information from current publications reported after the year 2000, with highlights on their herbal origins, structural variety, key spectroscopic characteristics for structural identification, potent bioactive synthetic derivatives, biological activity with possible SARs and application prospects. We hope the information in this paper can provide an overview on PIAs and PQAs and stimulate further investigation and application on them as pharmaceutical agents.

Occurrence of PIA and PQA analogues

The first isolation of PIAs was (R)-tylophorine (1) from Tylophora indica (Asclepiadaceae family) (Rathnagiriswaran and Venkatachalam 1935), so PIA analogues were also typified as Tylophora alkaloids sometimes. After then, from the other 17 Tylophora species, the trace of PIAs had been discovered by Karnick (Karnick 1975). In the last two decades, from other genera of Asclepiadaceae family, such as Cynanchum, Vincetoxzcum, and Antitoxzcum, a series of PIAs were isolated. Moreover, three species of Cryptocarya genus (Lauraceae family) and four species of Ficus genus (Moraceae family) also could supply natural PIAs.

Natural resources of PQAs were very rare. (R)-cryptopleurine (81) was the first isolation of PQA analogue from Cryptocarya pleurosperma (Lande 1948). After then, from the other Cryptocarya species, five species of Boehmeria genus, one species of Pilea (Urticaceae family) and one species of Citsus (Vitaceae family), another eight PQA analogues were obtained up to date.

Specific herbal origins of isolated PIAs and PQAs were summarized in Tables 1 and 2.

Structural variations of isolated PIAs and PQAs

Up to date, more than 100 PIAs and nine PQAs have been isolated from natural source. Naturally occurring PIAs and PQAs obtained before the year 2000 had been summarized in a few reviews (Govindachari and Viswanathan 1978; Gellert 1982; Li et al. 2001). This paper mainly mentioned those natural PIA and PQA analogues (including newly isolated and known ones) isolated in the last two decades. Except the different substituents, such as methoxyl or hydroxy group, etc., structural diversity of isolated PIAs and PQAs mainly associated with their skeleton variations of N-oxide (I-2), dehydrogenation (I-3) and cycloreversion (I-4 and II-2) (Fig. 2).

Fig. 2

Skeleton variations of the isolated PIAs (I-1–I-4) and PQAs (II-1 and II-2)

For PIA analogues, most of them possessed the basic skeleton I-1. According to the different orientation of the H-13a (α- or β-), C-13a possessed R- (1–20, Fig. 3) or S- (21–40, Fig. 4) stereo configuration. Interestingly, recent research indicated the stereochemistry of C-13a might be mainly linked to the methoxy-substitution pattern of the phenanthrene portion. If an oxygen substituent was present at C-2, while C-7 was free, R-configuration was observed. However, if C-7 was oxygenated and C-2 was unsubstituted, the S-configurated alkaloid was produced instead. If both C-2 and C-7 all carried a methoxy group, a low optical purity was observed (Stoye et al. 2013). Moreover, C-14 of some PIAs with skeleton I-1 could be substituted by a hydroxy group with trans or cis configuration to H-13a. Among them, compounds 16–18 (13aR,14R) and 28–36 (13aS,14R) possessed a trans configuration, however, compounds 19 and 20 (13aR,14S), 37–39 (13aS,14S) were all with a cis configuration. Compound 36 was the first glucoside of PIAs isolated from nature, hispiloscine (40) firstly obtained with an acetoxy substitution at C-14 naturally, and tengechlorenine (40) was the first naturally occurring halogenated PIA derivative.

Fig. 3

Structures of isolated PIAs with 13aR- configuration

Fig. 4

Structures of isolated PIAs with 13aS- configuration

Nitrogen atom in PIAs could be further oxidized to yield N-oxides (41–66, Fig. 5). Four kinds of relative configurations between H-13a and N-oxide group could be generated in PIA N-oxides (10S,13aR; 10R,13aS; 10R,13aR and 10S,13aS). Compounds 41–52 were N-oxides all with 10S,13aR absolute configurations and 53–60 with 10R,13aS stereochemistry. H-13a and N-oxide group in 61–66 were all cis configuration, while 61–64 were 10R,13aR and 65, 66 were 10S,13aS. Furthermore, N-oxides also could be hydroxylated at C-14 and more of them possessed the trans configuration with H-13a (47–51, 57–60), only compounds 52, 55 and 56 were found to be the cis configuration.

Fig. 5

Structures of isolated PIAs N-oxides

Indolizidine moiety of PIAs could undergo further dehydrogenation in ring D (67–69) or ring E (70) to give rise to dehydro- analogues (Fig. 6). These structural variations either extended the conjugated system, or increased the rigidity and planarity of the whole structure skeleton. In addition, the phenanthrene moiety could be cracked between C-4a and 4b to yield seco-PIA derivatives (71–80) (Fig. 6). On the foundation of which, further oxidation also could generate on the nitrogen atom to get a N-oxide (79), or undergo further dehydrogenation in ring D to give rise to a dehydro- analogue (80).

Fig. 6

Structures of isolated dehydro- (67–70) and seco- (71–80) PIAs

Comparing with PIAs, fewer naturally occurring PQAs were isolated. Up to now, only nine PQAs analogues (81–89) were obtained from the Lauraceae, Vitaceae and Urticaceae family of plants (Fig. 7). Their skeleton variations mainly were revealed by the stereochemistry of C-14a (81 and 88) and the seco-phenanthrene moiety (89).

Fig. 7

Structures of isolated PQAs

Key spectroscopic characteristics of PIAs and PQAs

UV spectra could be used to differentiate those dehydro-analogues with an aromatic D-ring (67–69, Fig. 6). Their conjugated chromophoric system between the phenanthrene moiety and D-ring in the skeleton caused a main maximum absorption (λmax) at approximately 280 nm with a shoulder peak at 255–260 nm in their UV spectra, while λmax of other PIAs could be recorded at 260 nm with a shoulder at 280–285 nm, which indicated the D-ring was saturated (Cui et al. 2004).

Except those dehydro- analogues, such as compounds 67–70, almost all the PIA and PQA derivatives could be involved in the stereochemistry determination of C-13a (for PIAs) or C-14a (for PQAs). With regards to the configuration at C-13a, it appeared that PIAs with the S- configuration exhibited a positive optical rotation, the opposite was observed with the R- configuration. Variation in the substituents and substitution pattern in both the phenanthrene and indolizidine moieties did not seem to significantly alter the optical rotational properties of the alkaloids (Yap et al. 2015). Furthermore, CD or ORD technique also was used to resolve this problem by the following rule: the positive optical rotation with the negative Cotton effect at approximately λ 260 nm corresponding to the C-13aS configuration, however, the negative optical rotation and a positive Cotton effect for alkaloids with the 13aR configuration (Damu et al. 2009). These conclusions also could be applied to PQAs for the stereochemistry determination of C-14a (Cai et al. 2006; Thuy et al. 2019). Based on the stereochemistry of C-13a, the relative configuration of the hydroxy group at C-14 could be determined by the coupling constant (J) or NOE between H-14 and H-13a (Lee et al. 2011; Yap et al. 2015; Chen et al. 2019a). For N-oxides, the resonance due to H-13a at approximately δ 3.5 was indicative of the trans-fused indolizidine ring junction, however, cis-fused junction resulted in the resonance of H-13a at approximately δ 4.0 (Damu et al. 2005, 2009; Chen et al. 2016).

In addition, mass spectrometry (MS) could reveal the relationship between the interesting fragmentation behavior and the molecular structure. Commonly, PIAs with a saturated D-ring always mainly produced two fragment ions via the retro-Diels–Alder (RDA) cleavage reactions. The fragmentation behavior in the positive FAB-MSn or ESI-MSn depended on the protonated position at the nitrogen atom or in the aromatic ring. When the nitrogen atom was protonated, the RDA cleavage easily produced the peak of the protonated dihydropyrrole ( , m/z 70), while when the H+ was added to the aromatic ring, the ion corresponding to the substituted phenanthrene moiety ([M + H − 69]+) was preferentially formed. Accordingly, the ion of protonated oxidized (N-oxide) dihydropyrrole ( , m/z 86) or [M + H − 87]+ could be derived from PIA N-oxides via the RDA cleavage reaction, however, those quaternary PIA analogues, such as compounds 67–69, could easily produce the molecular ions [M]+, while those fragments arose from the RDA cleavage were not observed because of the aromatic D-ring. For PIAs with a hydroxyl group substituted at C-14, the [M + H]+ ion was easily dehydrated to give an [M + H − H2O]+ ion, while the relative abundances of [M + H − 69]+ or [M + H − 87]+ (N-oxide) ions produced by the RDA cleavage reaction became lower since the relevant reactions were not as competitive (Xiang et al. 2002; Cui et al. 2004). Collision-induced dissociation spectra of tylophoridicine C (62) by the positive FAB-MS might typically interpret the primary fragmentation pathway of PIAs (Fig. 8, Xiang et al. 2002). Based on the fragmentation behavior of MS, liquid chromatography combining with MS and UV techniques had been applied on line successfully to detect PIA derivatives or metabolites in the crude extract of herbal medicine (Cui et al. 2004), rat urine (Tian et al. 2012) and rat plasma (Yu et al. 2015).

Fig. 8

Fragmentation pathway proposed to account for the CID spectra of tylophoridicine C (62) by positive ion FAB-MS. The structure of compound 62 was firstly elucidated to be (13aS,14S)-6,14-dihydroxy-3,7-dimethoxyphenanthroindolizidine N-oxide from T. atrofolliculata, also named as tylophoridicine C (Huang et al. 2004), while its name of 3,6,7-trimethoxy-10-oxyphenanthroindolizidine for FAB-MS in the reference was incorrect (Xiang et al. 2002)

Biological activities of PIAs and PQAs

New advance on anticancer activity

The favorable study on anticancer activity after the year 2015 was the isolation of PIA analogues from T. atrofolliculata as the hypoxia induced factor 1 (HIF-1) inhibitor (Chen et al. 2016, 2019a). HIF-1 plays a significant role in the adaption and survival of cancer cells under hypoxic conditions (Nagle and Zhou 2006). Among those 23 isolated PIAs, compounds 22, 28, 29, 30, 31, 32, 37, 48, 49, 62 (Chen et al. 2016) and 6-O-β-D-glucopyranosyl-tylophorinidine (36, Chen et al. 2019a), exhibited potent HIF-1 inhibitory activity in low nanomolar level with IC50 values ranging from 3 to 69 nM, which was more potent than digoxin, the positive control (IC50 302 nM). Compounds 30, 31 and 49 exhibited the most potent activity with IC50 values < 10 nM (Chen et al. 2016). Inhibitory results indicated that substitution types and patterns on the phenanthrene unit (hydroxy and methoxy groups) and the indolizidine ring (amide and N-oxides) could influence the bioactivity. The favorable structure–activity relationship (SAR) possibly was established in Fig. 9 based on the bioassay results (Chen et al. 2016, 2019a).

Fig. 9

Possible SARs on the HIF-1 inhibitory activity of PIAs analogues. SARs were deduced entirely from the HIF-1 inhibitory results of natural PIA analogues isolated from T. atrofolliculata (Chen et al. 2016, 2019a)

In addition, (R)-antofine (2) was firstly reported to effectively inhibited the proliferation of Met-mutated Caki-1 cells, which were resistant to well-known Met tyrosine kinase inhibitors. It could negatively regulated Met endosomal signaling in renal cancer cells and consequently inhibited the nuclear translocation of STAT3 both in vitro and in vivo (Song et al. 2015). Another two new seco-PIA analogues, fistulopsines A (73, GI50 3.45 and 2.37 μM) and B (78, GI50 7.04 and 5.96 μM) showed in vitro growth inhibitory activity in breast carcinoma cell MCF7 and colon carcinoma cell HCT 116 cell lines, by arresting cells in G1 phase without induction of apoptosis (Yap et al. 2016). The rare chlorinated derivative tengechlorenine (40) showed pronounced in vitro cytotoxic activity against three breast cancer cell lines tested (MDA-MB-468, MDA-MB-231, and MCF7; IC50 values of 0.038, 0.48 and 0.91 μM) (Al-Khdhairawi et al. 2017).

Four PQA analogues (86–89) including two new ones (86 and 87) were evaluated for their cytotoxicity against four cancer cell lines: KB (mouth epidermal carcinoma cells), HepG-2 (human liver hepatocellular carcinoma cells), LU-1 (human lung adenocarcinoma cells), and MCF-7 (human breast cancer cells). Pileamartine D (87) showed strong and selective inhibition toward KB and HepG-2 cells with IC50 values of 25 and 27 nM, respectively. Pileamartine C (86), julandine (89), and cryptopleurine (88) exhibited cytotoxicity against these four tested cancer cell lines with IC50 values less than 1 µM. PQA derivatives with the seco skeleton could reduce the cytotoxicity (88 vs. 89), while the free hydroxyl group at C-3 seemed to be critical for the bioactivity because pileamartine D (87) was more active than S-cryptopleurine against 3 cancer cell lines (KB, HepG-2 and LU-1) (Thuy et al. 2019).

Anti-inflammatory activity

Anti-inflammatory activities of four naturally occurring PIAs, including R-tylophorine (1), R-antofine (2), ficuseptine-A (59), and dehydrotylophorine (68), were all examined on the Raw264.7 macrophage cell model in vitro induced by LPS/IFNγ by detecting the suppression of different proinflammatory cytokines such as NO, TNFα, etc., they all exhibited potent suppression of NO in nanomolar or micromolar level (Yang et al. 2006, 2007; Min et al. 2010; Chou et al. 2017). Furthermore, R-antofine (2) was also indicated it could attenuate the metabolic disorders induced by inflammation via AMP-activated protein kinase as one possible molecular mechanism (Chou et al. 2017).

Based on the anti-inflammatory activities of these four naturally occurring PIAs, a series of synthesized derivatives of R-tylophorine (1) and R-antofine (2) were applied to the anti-inflammatory activity, and the possible structural requirements for the inhibition of NO production were suggested (Fig. 10). Tylophorine (1) exhibited much better activities than its framework (s-1) indicated the four methoxy groups at C-2, 3, 6 and 7 positions of the phenanthrene moiety contributed significant potency (Yang et al. 2007). However, inhibition of NO production of a series of synthesized derivatives of antofine (2) confirmed the methoxy group at C-2 and C-6 might be mandatory, and the methoxy group at C-7 with an insignificant function, which was confirmed by the NO suppression IC50 values of s-4–s-8 comparing with tylophorine (1) and antofine (2) (Min et al. 2010). Besides, keeping the non-planar structure of the indolizidine moiety was very vital for their anti-inflammatory activity. The quaternary PIA analogue, such as dehydrotylophorine (s-2), or the introduction of a keto group to C-9 (s-3), these structural modifications increased the rigidity and planarity of the whole structure skeleton or changed the amine group to an amide, could greatly reduce their bioeffects. Comparing the results of tylophorine (1) with 7-methoxycryptopleurine (s-9), it might deduce that the PQAs were more potent than their PIA counterparts for anti-inflammatory activity (Yang et al. 2007).

Fig. 10

Possible SARs of anti-inflammatory activity based on the NO suppression IC50 values of tylophorine (1) and antofine (2). Tylophorine (1) and its derivatives (s-1–s-3 and s-9) could be prepared by synthetic methods (Chuang et al. 2006). Antofine (2) and its synthesized derivatives (s-4–s-8) were obtained as described by Fu and his co-workers (Fu et al. 2007)

Antiviral activity

Anti-coronaviral activity

Tylophorine analogues, including naturally occurring and synthetic PIAs and PQAs, as potent inhibitors of enteropathogenic coronavirus transmissible gastroenteritis virus (TGEV), human severe acute respiratory syndrome coronavirus (SARS CoV), and mouse hepatitis virus (MHV), were investigated in vitro (Yang et al. 2010; Lee et al. 2012). Among them, compounds 31 and 33, two natural PIA analogues isolated from T. ovata, and a synthetic PQA derivative, 7-methoxycryptopleurine (s-9), potently inhibited TGEV replication with EC50 values at 18, 8 and 20 nM, respectively, and also possessed high selectivity index (SI) values. Tylophorine (1), 7-methoxycryptopleurine (s-9), and tylophorinine (37), were found to have profound activity against SARS CoV with EC50 values at 18, < 5, and < 5 nM determined by cytopathic assay under microscopic observation. Further detailed antiviral mechanism of tylophorine-based compounds at molecular level was investigated. They could exert potent anti-TGEV replication by directly targeting the viral RNA/ribonucleoprotein (RNP) complex for viral replication/synthesis, and also could inhibit the nuclear factor κB activation associated with IKK-2_IκBα/p65 axis and JAK pathway mediated p65 phosphorylation (Yang et al. 2017). Moreover, tylophorine (1) also potently inhibited the cytopathic effect and antiviral protein expression in infected DBT cells induced by MHV at < 0.2 μM (Lee et al. 2012).

Based on the antiviral results of those naturally occurring and synthetic PIA and PQA derivatives, positive or negative structural requirements were also revealed (Fig. 11). Firstly, similar to that of anti-inflammatory activity, the non-planar structure of the indolizidine moiety was also vital for their anti-TGEV activity, because of the great decrease bioeffects of s-2 and s-3 comparing to that of tylophorine (1). Secondly, hydroxylation at C-14 and C-3 contributed significantly to the inhibitory activity (31 to 37). However, introduction of an -OAc group into the C-14 position decreased the activity (s-12 to 37). Moreover, introduction of a methoxyl group to position C-4 of tylophorine could decrease the inhibitory activity of the parent compound (s-10 to 1). Third, oxidation to the reactive nitrogen to form an N-oxide also could decrease the inhibition, such as the great less potency of s-13 to that of 1. Besides, the PQAs deferred to the above conclusions generally and were more potent than their PIA counterparts for the antiviral activity (s-9 to 1).

Fig. 11

Possible SARs of the anti-TGEV activity for PIA derivatives based on tylophorine (1). In the anti-TGEV assay, compounds 31, 33 and 37 were used as natural products from T. ovata (31 and 33) and T. indica (37). Other compounds were all synthesized derivatives (Yang et al. 2010)

Anti-HIV activity

Interestingly, in an in vitro against human immunodeficiency virus (HIV) assay, dehydroantofine (69), but not (R)-antofine (2) isolated from C. chinensis, suppressed HIV-infected H9 cell growth significantly with an EC50 of 1.88 μg/mL. This promising finding was the first example of a PIA analogue exhibiting anti-HIV activity. Thus, this compound type might provide a useful lead for anti-AIDS drug development (Wu et al. 2012).

Inhibitory activity against tobacco mosaic virus (TMV)

Plant viruses are pathogenic to more than 700 plants and cause significant yield losses in crop production worldwide. Among them, TMV has been voted as the most important plant virus in molecular plant pathology based on their perceived importance, scientifically or economically (Scholthof et al. 2011). For naturally occurring PIA analogues, (R)-antofine (2) was firstly found to have good antiviral activity against TMV in vitro (An et al. 2001). Subsequently, the other analogues, (R)-tylophorine (1), 6-O-desmethylantofine (14), and deoxytylophorinine (25), revealed nearly the same in vitro TMV assembly inhibition as (R)-antofine (2) (Huang et al. 2007; Wang et al. 2007). The possible molecular mechanism against TMV was speculated as that they likely exerted its virus inhibition by binding to oriRNA and interfering with virus assembly initiation (Xi et al. 2006). They also could bind selectively with RNA bulged structures to disrupt interaction between TMV RNA and coat protein (Gao et al. 2012). An enlightened antiviral assay was then applied to some PQA analogues, such as (R)-cryptopleurine (81), (R)-boehmeriasin A (82), and boehmeriasin B (85), they also displayed potent antiviral activity against TMV (Wang et al. 2012c).

Now, ningnanmycin and ribavirin are two kinds of successful registered anti-plant viral agents and widely used for the treatment of TMV infection. Interestingly, the above natural PIA and PQA analogues all exhibited higher inhibitory activity against TMV than ribavirin, (R)-antofine (2), (R)-6-O-desmethylantofine (14), (R)-cryptopleurine (81), and boehmeriasin B (85) even revealed the better antiviral activity in vitro and in vivo than that of ningnanmycin (Wu et al. 2013; Wang et al. 2012c). Due to their potent antiviral activity against TMV, (R/S)-antofine (R/S)-tylophorine, (R/S)-cryptopleurine and (R/S)-boehmeriasin A were abundantly used to present interesting targets for total or semi synthesis, and SARs study for the development of agrochemicals against TMV infection. Series of synthetic PIA and PQA derivatives along with natural analogues were systematically evaluated on their antiviral activity, in order to investigate the precise structural requirements for the inhibition of TMV (Fig. 12). Generally, PQA and PIA derivatives possessed the similar SARs for their antiviral activity against TMV infection (Wang et al. 2012c, 2014). More detailed SARs of PIAs were established as follows:

Fig. 12

Structures of some typical PIA derivatives with their inhibition against TMV in vitro. In the anti-TMV assay, all the compounds were used as synthesized derivatives on the base of (R/S) -tylophorine or (R/S)-antofine. Their anti-TMV activity were revealed by the inhibition ratio (%) at 500 μg/mL. The inhibitions of ningnanmycin, a commercial antiviral agent as the positive control, were about 70% in different anti-TMV assays in vitro

The non-planar indolizidine moiety was the basic structural requirement for the anti-TMV effect.

Compound s-14, a synthetic derivative with a carbonyl group at C-9 of (S)-tylophorine (21), decreased the inhibitory activity in vitro. Its further dehydro-derivative in ring E, s-15, almost lost its antiviral activity. These structural modifications all increased the rigidity and planarity of the whole structure skeleton (Wang et al. 2012b).

The phenanthrene unit with hydroxy and alkoxy substituents were mandatory for the anti-TMV activity.

It seemed that 2,3,6- or 3,6,7-trimethoxylphenanthrene unit was more excellent than 2,3,6,7-trtramethoxylphenanthrene unit for the antiviral activity, because both (±)-antofine (2,3,6-trimethoxylphenanthrene unit) and (±)-deoxytylophorine (3,6,7-trimethoxylphenanthrene unit) exhibited better anti-TMV effects than (±)-tylophorine (2,3,6,7-trtramethoxylphenanthrene unit) (Wang et al. 2010, 2012b). Furthermore, for (R)-antofine (2), if the methoxyl at C-6 was changed to a hydroxyl group (14) or other hydrogen donor or electron-withdrawing groups (s-16–s-19), it was favorable for antiviral activity. Thus, antofine analogues with different C-6 substituents could be considered as a new class of antiviral agents (Wu et al. 2013).

The polar substituents (amino or hydroxyl group) at C-14 could influence the bioeffects, however, relating to the phenanthrene substitution pattern.

As anti-TMV agents, introduction of a hydroxyl at C-14 position of (±)-tylophorine could preserve the in vitro and in vivo antiviral activity, however, this structural modification could decrease the bioactivity of (±)-antofine and (±)-deoxytylophorine (Wang et al. 2012b). The similar decreased tendency could be found for the 14-NH2 substituted (S)-tylophorine (s-20) and (S)-antofine (s-21), although the 14-amino-deoxytylophorinine (s-22) preserved the similar high antiviral activity as its parent molecule, deoxytylophorinine (25). However, with the further acetylation, 14-acetamino substituted (S)-tylophorine (s-23) and (S)-antofine (s-24) increased their bioeffects, while the anti-TMV activity of 14-acetamino substituted (S)-deoxytylophorinine (s-25) was decreased obviously (Wang et al. 2012a, b).

Stereochemistry of C-13a with its substituted groups could change the bioactivity of PIAs.

Previously, Chemler summarized that C-2 methoxylation in the R-series, while C-7 methoxylation in the S-series, was very important for some PIAs to displayed their high anti-cancer activity, such as tylophorine, antofine, tylocrebrine and isotylocrebrine (Chemler 2009). Recent various antiviral bioassay against TMV basically approved this conclusion, especially confirmed by in vitro anti-TMV results of deoxytylophorine (Wang et al. 2012a) and 6-O-desmethylantofine (Wu et al. 2013). However, in vitro anti-TMV activity of (R/S)-tylophorine (Wang et al. 2010) and (R/S)-antofine (Wang et al. 2012a; Su et al. 2016) was nearly equal. Furthermore, introduction of other groups, such as methyl, methylcarboxyl, and hydroxymethyl, at C-13a of (R/S)-antofine, only the α-hydroxymethyl substituted derivative (s-26) was evaluated to greatly enhance the anti-TMV effects (Su et al. 2014, 2016). These results obviously demonstrated that the spatial configuration of the molecules was crucial for keeping high bioactivities and introduction of suitable functional groups at the C-13a position could accelerate this trend.

Salinization of N-10 could alter the anti-TMV activity because of the increasing stability and water solubility.

In general, PIAs salt derivates produced directly from (±)-tylophorine with inorganic acids or organic acids could enhance their antiviral effects, only its carbazotic acid salt (s-27) decreased its bioactivity (Wang et al. 2010). However, introduction of different substituents at N-10 to yield chiral quaternary ammonium salts could result in a negative effect for their anti-TMV activity, although the (S)-tylophorine derivative (s-28) produced with 3-bromoprop-1-yne greatly enhanced the antiviral activity. Moreover, anti-TMV activity of these chiral quaternary ammonium salts varied significantly depending upon the chirality of C-13a and N-10 following this sequence: 13aS > 13aR, and trans > cis (Han et al. 2018).

Antifungal activity

Recently, (R)-antofine (2) was investigated the inhibitory effect against plant-pathogenic fungi of Penicillium species. It showed strong antifungal activity against P. digitatum and P. italicum with an observed in vitro minimum inhibitory concentration (MIC, 1.56 and 1.56 µg/mL) and a minimum fungicidal concentration (MFC, 12.5 and 6.25 µg/mL). In vivo assays also showed that antofine could significantly reduce the incidence of green mold in citrus fruit. Both of them can be attributed to the disruption of the cell membrane integrity and energy metabolism (Xin et al. 2019; Chen et al. 2019b). Antifungal results indicated some PIAs could be used as natural fungicides for controlling postharvest green mold, blue mold, and sour rot disease of fruits and vegetables caused by Penicillium pathogens.

Insecticidal activity

Three PIA analogues, (R)-tylophorine (1), (R)-antofine (2) and (R)-antofine N-oxide (41), were isolated from C. mongolicum based on the bioassay-guided tracing. They all showed toxic effect against Spodoptera litura and the aphid Lipaphis erysimi. Compound 41 was more toxic than 1 and 2, but they were all less active against S. litura than total alkaloids. The contact toxicity of these alkaloids against the aphid L. erysimi was significant, as the 24 h-LC50 values of them and total alkaloids were 292.48, 367.21, 487.791 and 163.52 mg/L, respectively. In the development disruption of S. litura larvae, the pupation and emergence rates decreased and the acute mortality increased significantly by day 3 after being injected in their body cavity with 10–40 mg/L of total alkaloid. The ecdysone titer of treated S. litura larvae and prepupae also declined with increasing alkaloid concentration. The alkaloids of C. mongolicum could be used as potential insect growth inhibitors (Ge et al. 2015).

Anti-angiogenic activity

Both (R)-tylophorine (1) and (R)-antofine (2) were selected to the anti-angiogenic assay based on their excellent anti-proliferative activities in a variety of cancer cells. Antofine (2) could effectively inhibit the proliferation of both endothelial cell types, with IC50 435.5 nM in cultured mouse embryonic stem/embryoid body-derived endothelial cell and 36.0 nM in vascular endothelial growth factor (VEGF)-induced human umbilical vein endothelial cells (HUVECs), respectively. The underlying mechanism of its anti-angiogenic activity was, in part, associated with the modulation of AKT/mTOR and AMP-activated protein kinase (AMPK) signaling in VEGF-stimulated HUVECs. (Oh et al. 2017). Tylophorine (1) potently inhibited the PDGF-BB-induced proliferation of rat aortic vascular smooth muscle cells (VSMCs) in a concentration-dependent manner with an IC50 of 0.13 µM, by arresting cells in G1 phase of the cell cycle as well as migration in activated VSMCs. It could decrease de novo protein synthesis, result in downregulation of cyclin D1 and prevent neointimal thickening in human saphenous vein organ culture (Joa et al. 2019). Anti-angiogenic results indicated tylophorine (1) and antofine (2) could be used as promising lead compounds for further studies towards the treatment of vasculo-proliferative disorders, such as restenosis.

Anti-adipogenic activity

Antofine (1) was revealed with a novel anti-adipogenic activity at low concentrations (0.01–10 nM) to repress the proliferation and differentiation of preadipocyte 3T3-L1 cells without associated cytotoxicity. Its underlying molecular mechanism was to suppress the expression of endogenous peroxisome proliferator-activated receptor γ (PPARγ) protein in adipocytes, leading to the attenuation of PPARγ-induced adipogenic gene expression and consequent inhibition of adipocyte differentiation. Antofine could be used as a promising candidate in the control of obesity as well as tumor (Jang et al. 2014).

Antiplasmodial activity

Up to date, only phenanthroindolizine-type alkaloids in the extract of F. septica were reported on antimalarial activities. From the most potent chloroform-soluble portion, a new seco-phenanthroindolizinetype alkaloid, 4a,b-seco-dehydroantofine (80) with tylophoridicine D (67), dehydrotylophorine (68), and dehydroantofine (69), were isolated with IC50 values against a chloroquine-sensitive strain (3D7) of Plasmodium falciparum at 4.0, 0.058, 0.42, and 0.028 µM, respectively. Moreover, both 67 and 69 showed potent antimalarial activities comparative to those of positive controls, artemisinin (IC50 0.025 µM) and chloroquine (IC50 0.036 µM), but were inactive against mouse fibroblast cells L929. These results suggested that PIAs might be acted as therapeutic leads for new antimalarial drugs (Kubo et al. 2016).

Oviposition-stimulatory activity

A common danaid butterfly, Ideopsis similis (L.), exclusively attacks an asclepiadaceous plant, T. tanakae. In its pupae and imagines, trace of PIAs was detected as the sequestration phenomenon (Komatsu et al. 2001; Abe et al. 2001). A total of 12 PIAs isolated from T. tanakae were selected to evaluate their oviposition-stimulatory activity at a dose of 100 mg/cm2 on female danaid butterfly. Favorably, (+)-isotylocrebrine (27), (+)-3-demethylisotylocrebrine (26), (+)-isotylocrebrine N-oxide (61), and (-)-7-demethyltylophorine (15), induced the females to lay 28, 23, 15 and 25 eggs, respectively, larger numbers than that of water as the control (not more than 7 eggs). However, female egg-laying was much higher in response to a mixture of those alkaloids, which strongly suggested that host selection by the butterfly was mediated by the synergistic action of several PIAs present in the host plant. For the SARs, it was apparent that the introduction of a hydroxy group at C-14 and the formation of N-oxide considerably depressed the activity. In those with R-configuration, the presence of a hydroxy group rather than a methoxy one at C-7 appeared to increase stimulation of oviposition (Honda et al. 2001).

Application prospects of PIAs and PQAs

Although tylocrebrine (12) was advanced to clinical trials but failed due to its central nervous system (CNS) toxicity manifested as disorientation and ataxia, naturally occurring PIA and PQA analogues along with their total or semi synthetic derivatives still attract great attention all along as potent anti-cancer agents because of their excellent biological activities, such as the isolation of new natural analogues (Yap et al. 2016; Al-Khdhairawi et al. 2017; Chen et al. 2019a; Thuy et al. 2019), new synthetic methods and new anti-cancer mechanism on active agents (Chen et al. 2016; Wang et al. 2018; Jo et al. 2019; Shimada et al. 2019), etc. Therefore, it is worthwhile to carry out further investigations on natural species and organic reactions for more novel PIA and PQA analogues with great bioeffects. To investigate the precise structural requirements of these kinds of compounds for suppressing their neurotoxicity and other toxic effects also may be one of the study directions.

In addition, PIA and PQA analogues probably can act as the candidate of new antiviral agents against coronavirus. Pneumonia outbreaks caused by novel coronavirus, such as the previous SARS and the present COVID-19 caused by SARS-CoV-2 in the begin of the year 2020, are great threat to the public health, however, with few effective therapeutic drugs. Some PIA and PQA analogues, such as tylophorine (1), tylophorinine (37), and 7-methoxycryptopleurine (s-9), were found to have high potency against SARS CoV and TGEV in vitro at low nanomolar level with high oral availability in rats, which suggested they could be used as potential therapeutic agents for coronavirus infections (Yang et al. 2010; Lee et al. 2012). Moreover, the novel coronavirus, SARS-CoV-2, has been revealed almost identical to each other and shared 79.5% sequence identify to SARS-CoV (Zhou et al. 2020), these PIA and PQA analogues may be effective to CoV-2019. Therefore, it is worthwhile to carry out further investigations on PIA and PQA analogues as potent antiviral agents.

In addition, application of some PIAs as antifungal and antiviral agents against plant-pathogenic fungi of Penicillium species and TMV indicated this kind of compounds can be used as potential agrochemicals. Naturally occurring autofine (2), deoxytylophorinine (11), and 6-O-desmethylantofine (14), along with semi-synthetic derivatives, such as s-16–s-19, s-22, s-24, s-26 and s-28, etc., they all displayed the similar or more potent in vitro and in vivo antiviral activity than ningnanmycin, the successful registered anti-plant viral agents for the treatment of TMV infection. As the natural product based antiviral agents, some PIA and PQA derivatives can be used as ideal lead structures to develop more attractive agrochemicals with easy decomposition, environmental friendliness, specification to targeted species, or unique mode of action.

Conclusions

Besides of their promising anticancer activities with the structural modifications, this article mainly presented an overview of naturally occurring PIAs and PQAs obtained in the last two decades, focusing on their origins, structural variety, key spectroscopic characteristics, other biological activity with structure–activity relationships and application prospects. Their structural skeletons could suffer different modifications, such as oxidation (hydroxylation and carbonylation), dehydration, to result in the structural variety and associating with a wide spectrum of biological activities. Some PIA and PQA analogues exhibited very significant antiviral potentiality in nanomolar level against coronavirus. Moreover, their antifungal activity against Penicillium species and anti-TMV applications revealed their potentiality used as attractive agrochemicals. In brief, structural variations with excellent biological activities suggested these two kinds of compounds might be worthy of further study and may be valuable for the development of new drug or agrochemical candidates.